Order intake declined 3.9% year-over-year due to Middle East instability, but profitability improved with a 15.5% EBITDA margin. Flow and Services divisions grew, while Chemtech faced headwinds and accelerated restructuring. Guidance for 2026 is confirmed.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.